ProQR Therapeutics N.V. PRQR
$ 3.98
0.38%
Annual report 2023
added 11-09-2024
Country |
Niderland |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Daniel De Boer |
Employees in the company |
154 |
Shares |
- |
Market Cap[1] |
$ 99.5 M |
EBITDA (LTM) |
$ -62 M |
P/E (LTM) |
-3.36 |
P/S (LTM) |
85.29 |
EPS (LTM) |
-0.92 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.